AT375640B - Verfahren zur herstellung von substituierten 2-azetidinonderivaten - Google Patents
Verfahren zur herstellung von substituierten 2-azetidinonderivatenInfo
- Publication number
- AT375640B AT375640B AT0396381A AT396381A AT375640B AT 375640 B AT375640 B AT 375640B AT 0396381 A AT0396381 A AT 0396381A AT 396381 A AT396381 A AT 396381A AT 375640 B AT375640 B AT 375640B
- Authority
- AT
- Austria
- Prior art keywords
- producing substituted
- azetidinone derivatives
- azetidinone
- derivatives
- substituted
- Prior art date
Links
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical class O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
- E04G9/00—Forming or shuttering elements for general use
- E04G9/02—Forming boards or similar elements
- E04G2009/023—Forming boards or similar elements with edge protection
- E04G2009/025—Forming boards or similar elements with edge protection by a flange of the board's frame
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU802264A HU181742B (en) | 1980-09-15 | 1980-09-15 | Process for producing new azetidinone derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA396381A ATA396381A (de) | 1984-01-15 |
| AT375640B true AT375640B (de) | 1984-08-27 |
Family
ID=10958582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0396381A AT375640B (de) | 1980-09-15 | 1981-09-14 | Verfahren zur herstellung von substituierten 2-azetidinonderivaten |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US4435322A (de) |
| AT (1) | AT375640B (de) |
| HU (1) | HU181742B (de) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0199630A1 (de) * | 1985-04-10 | 1986-10-29 | Merck & Co. Inc. | Substituierte Azetidinone, diese enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung zur Herstellung von entzündungshemmenden und antidegenerativen Medikamenten |
| US5100880A (en) * | 1991-03-20 | 1992-03-31 | Merck & Co., Inc. | Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
| US5104862A (en) * | 1991-03-20 | 1992-04-14 | Merck & Co., Inc. | Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
| US5229510A (en) * | 1983-12-01 | 1993-07-20 | Merck & Co., Inc. | β-lactams useful in determining the amount of elastase in a clinical sample |
| US5229381A (en) * | 1983-12-01 | 1993-07-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US5348953A (en) * | 1991-06-25 | 1994-09-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US5591737A (en) * | 1992-12-17 | 1997-01-07 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US5747485A (en) * | 1995-04-13 | 1998-05-05 | Merck & Co., Inc. | Substituted azetidiones as anti-inflammatory and antidegenerative agents |
| US5952321A (en) * | 1992-10-27 | 1999-09-14 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU187424B (en) * | 1982-11-05 | 1986-01-28 | Richter Gedeon Vegyeszeti Gyar Rt,Hu | Process for preparing new azetidinyl-acetic acids |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1145347A (en) | 1977-09-30 | 1983-04-26 | Akira Sato | 2-azetidinone derivatives |
| US4290947A (en) | 1979-04-27 | 1981-09-22 | Merck & Co., Inc. | Process for the preparation of thienamycin and intermediates |
-
1980
- 1980-09-15 HU HU802264A patent/HU181742B/hu not_active IP Right Cessation
-
1981
- 1981-09-11 US US06/301,191 patent/US4435322A/en not_active Expired - Fee Related
- 1981-09-14 AT AT0396381A patent/AT375640B/de not_active IP Right Cessation
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5229510A (en) * | 1983-12-01 | 1993-07-20 | Merck & Co., Inc. | β-lactams useful in determining the amount of elastase in a clinical sample |
| US5229381A (en) * | 1983-12-01 | 1993-07-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| EP0199630A1 (de) * | 1985-04-10 | 1986-10-29 | Merck & Co. Inc. | Substituierte Azetidinone, diese enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung zur Herstellung von entzündungshemmenden und antidegenerativen Medikamenten |
| US5100880A (en) * | 1991-03-20 | 1992-03-31 | Merck & Co., Inc. | Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
| US5104862A (en) * | 1991-03-20 | 1992-04-14 | Merck & Co., Inc. | Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
| US5348953A (en) * | 1991-06-25 | 1994-09-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US5952321A (en) * | 1992-10-27 | 1999-09-14 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US5591737A (en) * | 1992-12-17 | 1997-01-07 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US5747485A (en) * | 1995-04-13 | 1998-05-05 | Merck & Co., Inc. | Substituted azetidiones as anti-inflammatory and antidegenerative agents |
Also Published As
| Publication number | Publication date |
|---|---|
| HU181742B (en) | 1983-11-28 |
| US4435322A (en) | 1984-03-06 |
| ATA396381A (de) | 1984-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT380476B (de) | Verfahren zur herstellung von chinazolinderivaten | |
| AT378768B (de) | Verfahren zur herstellung von neuen 1-sulfo-2-oxoazetidin-derivaten | |
| ATA420581A (de) | Verfahren zur herstellung von pyrimidonderivaten | |
| ATA368281A (de) | Verfahren zur herstellung von triazolderivaten | |
| AT376654B (de) | Verfahren zur herstellung von neuen 1-phenyl-2cyclohexen-1-alkylamin-derivaten | |
| AT374827B (de) | Verfahren zur herstellung von cholesterase | |
| AT375640B (de) | Verfahren zur herstellung von substituierten 2-azetidinonderivaten | |
| ATA76984A (de) | Verfahren zur herstellung von carbapenem-derivaten | |
| AT367436B (de) | Verfahren zur herstellung von copolymerisaten | |
| AT379388B (de) | Verfahren zur herstellung von neuen 4-chinolonderivaten | |
| AT375076B (de) | Verfahren zur herstellung von neuen ergolinderivaten | |
| AT380686B (de) | Verfahren zur herstellung von buspiron | |
| AT373891B (de) | Verfahren zur herstellung von neuen rifamycinderivaten | |
| AT374451B (de) | Verfahren zur herstellung von neuen benzylidenderivaten | |
| AT375328B (de) | Verfahren zur herstellung von sintermagnesia | |
| AT381940B (de) | Verfahren zur herstellung von neuen ergolinderivaten | |
| ATA110780A (de) | Verfahren zur herstellung von o-trimethylsilyl- -cellulosen | |
| AT370716B (de) | Verfahren zur herstellung von naphthacendionderivaten | |
| AT378184B (de) | Verfahren zur herstellung von 4-amino-1,2hydrocarbyl-pyrazolidinen | |
| AT369383B (de) | Verfahren zur herstellung von beta-amidoethyl -ether-derivaten | |
| AT380249B (de) | Verfahren zur herstellung von alkoxy-vincamon-derivaten | |
| AT375083B (de) | Verfahren zur herstellung von 1alfa,25-dihydroxycholesterin | |
| ATA328581A (de) | Verfahren zur herstellung von 1-phenoxy-3-amino- 2-propanolen | |
| AT381095B (de) | Verfahren zur herstellung von pendamderivaten | |
| AT374482B (de) | Verfahren zur herstellung von neuen 3-thiovinylcephalosporinderivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee | ||
| ELJ | Ceased due to non-payment of the annual fee |